Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 326 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Troubles rétiniens d'origine médicamenteuse. Prescrire 2019;39:19-25. [Ref.ID 103005]
2. Cita con resumen
Hammann F, Gotta V, Conen K, Medinger M, Cesana P, Rochlitz C, Taegtmeyer AB. Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity. Br J Clin Pharmacol 2017;83:927-30. [Ref.ID 101972]
3. Cita con resumen
Anónimo. Clopidogrel: augmentation des effets indésirables du paclitaxel. Prescrire 2017;37:344-5. [Ref.ID 101651]
4. Cita con resumen
Anónimo. Pembrolizumb et mélanomes métastasés ou inopérables. Prescrire 2016;36:889-91. [Ref.ID 101003]
5.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
6. Cita con resumen
Anónimo. Bévacizumab et cancer épithélial de l'ovaire résistant aux sels de platine. Prescrire 2015;35:656-7. [Ref.ID 99713]
8.Enlace a cita original Cita con resumen
Hawkes N. NHS England drops 16 medicines from Cancer Drugs Fund. BMJ 2015;351:h4803. [Ref.ID 99469]
9. Cita con resumen
Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, Vlachonjannis GJ, Jensen LO, Christiansen EH, Berencsi K, Valgimigli M, Orlandi C, Petrou M, Rapezzi C, Stone GW. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2015;65:2496-507. [Ref.ID 99444]
10. Cita con resumen
Del Mastro L, De Placido S, Bruzzi P, De Laurentiis M, Boni C, Cavazzini G, Durando A, Turletti A, Nisticò C, Valle E, Garrone O, Puglisi F, Montemurro F, Barni S, Ardizzoni A, Gamucci T, Colantuoni G, Giuliano M, Gravina A, Papaldo P, Bighin C, Bisagni G, Forestieri V, Cognetti F, for the Gruppo Italiano Mammella (GIM) investigators. Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2?×?2 factorial, randomised phase 3 trial. Lancet 2015;385:1863-72. [Ref.ID 99090]
11. Cita con resumen
Anónimo. Paclitaxel lié à l'albumine et cancer du pancréase métastasé. Prescrire 2015;35:97-8. [Ref.ID 98913]
12. Cita con resumen
13. Cita con resumen
Torregrosa JL, Fernández M, Garcías J, Pérez A. Morfea en placas inducidas por paclitaxel. Med Clin (Barc) 2014;142:424-5. [Ref.ID 97545]
14. Cita con resumen
Anónimo. FDA approves Cyramza for stomach cancer. U.S. Food and Drug Administration 2014:21 de abril. [Ref.ID 97452]
15.Tiene citas relacionadas
Bangalore S, Toklu B, Amoroso N, Fusaro M, Kumar S, Hannan EL, Faxon DP, Feit F. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ 2013;347:f6625. [Ref.ID 97174]
16.Tiene citas relacionadas Cita con resumen
Navarese EP, Tandjung K, Claessen B, Andreotti F, Kowalewski M, Kandzari D, Kereiakes D, Waksman R, Mauri L, Meredith IT, Finn AV, Kim HS, Kubica J, Suryapranata H, Mustahsani T, Di Pasquale G, von Birgelen C, Kedhi E. Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis. BMJ 2013;347:f6530. [Ref.ID 97173]
18. Cita con resumen
Anónimo. Neuropathies périphériques d'origine médicamenteuse. Prescrire 2013;33:269-75. [Ref.ID 95342]
19. Cita con resumen
Smith EML, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL, for the Alliance for Clinical Trials in Oncology. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy. A randomized clinical trial. JAMA 2013;309:1359-67. [Ref.ID 95235]
20. Cita con resumen
Byrne RA, Neumann F-J, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz K-L, Massberg S, Kastrati A, for the ISAR-DESIRE 3 investigators. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 2013;381:461-7. [Ref.ID 94918]
Seleccionar todas
 
 1 a 20 de 326 siguiente >>